Skip to main content

Endothelial Dysfunction and Atherothrombosis

  • Chapter
Atlas of Atherosclerosis
  • 123 Accesses

Abstract

Located at the interface between the vessel wall and circulating blood, the vascular endothelium plays a critical role in the homeostatic and physiologic functions of the vasculature. In response to biochemical and mechanical stimuli, endothelial cells synthesize and elaborate a number of factors that modulate vascular tone, inflammation, thrombosis, and vascular growth. Normal endothelium provides a fluid antiatherogenic environment that inhibits platelet and leukocyte adhesion, prevents vasospasm, promotes fibrinolysis, and inhibits vascular smooth muscle cell growth. Under pathologic conditions when homeostatic mechanisms are altered, the phenotypic changes that occur in endothelial cells support a vasospastic, prothrombotic, and proinflammatory milieu, and play a central role in the pathophysiology and clinical manifestation of cardiovascular disease [1].

“...the fluidity of blood within the living body depends upon the action of the walls of the vessel upon it...” (Ernst Von Brücke, 19th Century Viennese physiologist)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Levine GN, Keaney JF, Jr, Vita JA: Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995, 332: 512–521.

    Article  PubMed  CAS  Google Scholar 

  2. Moncada S, Higgs A: The L-arginine nitric oxide pathway. N Engl J Med 1993, 329: 2002–2012.

    Article  PubMed  CAS  Google Scholar 

  3. Vita JA, Treasure CB, Nabel EG, et al.: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990, 81: 491–497.

    Article  PubMed  CAS  Google Scholar 

  4. Vaughan DE, Schafer AI, Loscalzo J: Normal mechanisms of hemostasis and fibrinolysis. In Vascular Medicine. A textbook of vascular biology and diseases. Edited by Loscalzo J, Creager MA, Dzau VJ: Boston, Little, Brown and Company; 1996: 207–216.

    Google Scholar 

  5. Ross R: Atherosclerosis:an inflammatory disease. [Review]. N Engl J Med 1999, 340: 115–126.

    Article  PubMed  CAS  Google Scholar 

  6. Allen S, Khan S, Al-Mohanna F, et al.: Native low density lipoprotein—induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 1998, 101: 1064–1075.

    Article  PubMed  CAS  Google Scholar 

  7. Celermajer DS, Sorensen KE, Georgakopoulos D, et al.: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993, 88:2149–2155.

    Google Scholar 

  8. Johnstone MT, Creager SJ, Scales KM, et al.: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993,88:2510–2516.

    Google Scholar 

  9. Bellamy MF, McDowell IFW, Ramsey MW, et al.: Hyperhomocystinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998, 98:1848–1852.

    Google Scholar 

  10. Keaney JF, Jr, Vita JA: Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 1995, 38: 129–154.

    Article  Google Scholar 

  11. Gokce N, Keaney JF, Jr, Vita JA: Endotheliopathies: Clinical manifestations of endothelial dysfunction. In Thrombosis and Hemorrhage. Edited by Loscalzo J, Shafer AI. Williams and Wilkins, 1998; 901–924.

    Google Scholar 

  12. Ross R, Glomset JA: The pathogenesis of atherosclerosis (part 1). N Engl J Med 1976, 295: 369–377.

    Article  Google Scholar 

  13. Luscher T, Noll G: Coronary blood flow and myocardial ischemia. In Heart Disease. Edited by Braunwald E: Philadelphia, WB Saunders; 1997: 1161–1184.

    Google Scholar 

  14. Furchgott R: Role of endothelium in responses of vascular smooth muscle. Circ Res 1983, 53: 557–573.

    Article  Google Scholar 

  15. Ludmer PL, Selwyn AP, Shook TL, et al.: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986, 315:1046–1051.

    Google Scholar 

  16. Vita JA, Treasure CB, Yeung AC, et al.: Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992, 85:1390–1397.

    Google Scholar 

  17. Yeung AC, Vekshtein VI, Krantz DS, et al.: The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991, 325:1551–1556.

    Google Scholar 

  18. Bogaty P, Hackett D, Davies G, Maseri A: Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994, 90: 5–11.

    Article  Google Scholar 

  19. Egashira K, Inou T, Hirooka Y, et al.: Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993, 328:1659–1664.

    Google Scholar 

  20. Taddei S, Virdis A, Mattei P, et al.: Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996, 94:1298–1303.

    Google Scholar 

  21. Panza JA, Quyyumi AA, Brush JE, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323: 22–27.

    Article  Google Scholar 

  22. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998, 338: 1042–1050.

    Article  PubMed  CAS  Google Scholar 

  23. Anderson TJ, Uehata A, Gerhard MD, et al.: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235–1241.

    Google Scholar 

  24. Vita JA, Keaney JF, Jr: Ultrasound assessment of endothelial vasomotor function. In Diagnostics of Vascular Diseases: Principals and Technology. Edited by Lanzer P, Lipton M: Berlin: Springer, 1996; 249–259.

    Google Scholar 

  25. Lieberman EH, Gerhard MD, Uehata A, et al.: Flow-induced vasodilation of the human brachial artery is impaired in patients 40 years of age with coronary artery disease. Am J Cardiol 1996, 78:1210–1214.

    Google Scholar 

  26. Cooke JP, Dzau JV: Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular disease. Circulation 1997, 96: 379–382.

    Google Scholar 

  27. Rajagopalan S, Kurz S, Munzel T, et al.:Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest 1996, 97: 1916–1923.

    Article  Google Scholar 

  28. Cohen RA: Endothelium-derived vasoactive factors. In: Thrombosis and Hemorrhage. Edited by Loscalzo J, Shafer AI Williams and Wilkins; 1998: 387–404.

    Google Scholar 

  29. Stein B, Khew-Goodall, Gamble J, Vadas MA: Transmigration of leukocytes. In The Endothelium in Clinical Practice- Source and Target of Novel Therapies. Edited by Rubanyi GM, Dzau JV. New York, Marcel Dekker; 1997: 149–202.

    Google Scholar 

  30. Mihm S, Galter M, Droge W: Modulation of transcription factor NF kappa B activity by intracellular glutathione levels and by varia- tions of the extracellular cysteine supply. FASEB 1995, 9: 246–252.

    Google Scholar 

  31. Kojda G, Harrison DG: Interactions between NO and reactive oxygen species: pathophysiologic importance in atherosclerosis, hypertension, diabetes, and heart failure. Cardiovascular Research 1999, 43: 562–571.

    Article  Google Scholar 

  32. Ross R: The pathogenesis of atherosclerosis. In Heart Disease: A Textbook of Cardiovascular Disease. Edited by Braunwald E. Philadelphia: W.B. Saunders; 1997: 1105–1125.

    Google Scholar 

  33. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362: 801–809.

    Article  PubMed  Google Scholar 

  34. Mendelsohn ME, Loscalzo J: The Endotheliopathies. In Vascular Medicine. Edited by Loscalzo J, Creager MA, Dzau J. Little, Brown and Company; 1992: 279–305.

    Google Scholar 

  35. Dobroski DR, Rabbani LE, Loscalzo J: The relationship between thrombosis and atherosclerosis. In Thrombosis and Hemorrhage. Edited by Loscalzo J, Shafer AI. Williams and Wilkins; 1998: 837–861.

    Google Scholar 

  36. Makrides SC, Ryan US: Overview of the endothelium. In Thrombosis and Hemorrhage. Edited by Loscalzo J, Schafer AI. Williams and Wilkins; 1998: 295–306.

    Google Scholar 

  37. Broze GJ: The tissue factor pathway of coagulation. In Thrombosis and Hemorrhage. Edited by Loscalzo J, Shafer AI. Williams and Wilkins; 1998: 77–104.

    Google Scholar 

  38. Levine GN, Keaney JF, Jr, Vita JA: Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995, 332: 512–521.

    Article  Google Scholar 

  39. Anderson TJ, Meredith IT, Yeung AC, et al.: The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995, 332:488–493.

    Google Scholar 

  40. Mancini GB, Henry GC, Macaya C, et al.: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996, 94:258–265.

    Google Scholar 

  41. Vaughan DE, Rouleau J, Ridker PM, et al.: Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation 1997, 96: 442–447.

    Google Scholar 

  42. Gokce N, Keaney JF, Jr., Frei B, et al.:Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999, 99: 3234–3240.

    Article  Google Scholar 

  43. Boger RH, Boder-Boger SM, Thiele W, et al.: Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 1998, 2:1336–1344.

    Google Scholar 

  44. Pepine CJ: The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia. Am J Cardiol 1998, 82(10[A]):235–275.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gokce, N., Loscalzo, J. (2000). Endothelial Dysfunction and Atherothrombosis. In: Wilson, P.W.F. (eds) Atlas of Atherosclerosis. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-9310-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9310-9_2

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-9312-3

  • Online ISBN: 978-1-4757-9310-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics